{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:44:45Z","timestamp":1792640685416,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["US005"],"award-info":[{"award-number":["US005"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Nationale Contre Le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004711","name":"Chung Hua University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","award":["UMS3427"],"award-info":[{"award-number":["UMS3427"]}],"id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005897","name":"Soci\u00e9t\u00e9 Fran\u00e7aise de Dermatologie et de Pathologie Sexuellement Transmissible","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006251","name":"Universit\u00e9 de Bordeaux","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006251","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jid.2022.06.016","type":"journal-article","created":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T04:36:33Z","timestamp":1657946193000},"page":"3243-3252.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cutaneous Lymphocyte Antigen Is a Potential\u00a0Therapeutic Target in Cutaneous T-Cell Lymphoma"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1763-2413","authenticated-orcid":false,"given":"Sara","family":"Peru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7719-7679","authenticated-orcid":false,"given":"Martina","family":"Prochazkova-Carlotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4181-0283","authenticated-orcid":false,"given":"Floriane","family":"Cherrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1346-3608","authenticated-orcid":false,"given":"Joanne","family":"Velazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3778-1210","authenticated-orcid":false,"given":"Elodie","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8654-5380","authenticated-orcid":false,"given":"Yamina","family":"Idrissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9634-2595","authenticated-orcid":false,"given":"David","family":"Cappellen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5575-2539","authenticated-orcid":false,"given":"Lamia","family":"Azzi-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2960-6084","authenticated-orcid":false,"given":"Anne","family":"Pham-Ledard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6150-1229","authenticated-orcid":false,"given":"Marie","family":"Beylot-Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0305-0850","authenticated-orcid":false,"given":"Jean-Philippe","family":"Merlio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8783-0709","authenticated-orcid":false,"given":"Sandrine","family":"Poglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2022.06.016_bib1","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.ajpath.2016.03.012","article-title":"Intrahepatic xenograft of cutaneous T-cell lymphoma cell lines: A useful model for rapid biological and therapeutic evaluation","volume":"186","author":"Andrique","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2022.06.016_bib2","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1182\/blood-2008-02-138172","article-title":"NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity","volume":"113","author":"Armstrong","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.06.016_bib3","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1084\/jem.174.6.1461","article-title":"The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1","volume":"174","author":"Berg","year":"1991","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2022.06.016_bib4","article-title":"Cucurbitacin E and I target the JAK\/ STAT pathway and induce apoptosis in S\u00e9zary cells","volume":"24","author":"Brouwer","year":"2020","journal-title":"Biochem Biophys Rep"},{"key":"10.1016\/j.jid.2022.06.016_bib5","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":"Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.06.016_bib6","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1158\/1535-7163.MCT-12-0278","article-title":"Humanization of an anti-CCR4 antibody that kills cutaneous T-cell lymphoma cells and abrogates suppression by T-regulatory cells","volume":"11","author":"Chang","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jid.2022.06.016_bib7","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.4049\/jimmunol.176.7.4431","article-title":"The vast majority of CLA+ T cells are resident in normal skin","volume":"176","author":"Clark","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2022.06.016_bib8","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41375-018-0305-8","article-title":"Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K\/AKT\/mTORC1 pathway and its prognostic relevance","volume":"33","author":"Cristofoletti","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.jid.2022.06.016_bib9","first-page":"359","article-title":"Functional evidence that the HECA-452 antigen is involved in the adhesion of human neutrophils and lymphocytes to tumour necrosis factor-alpha-stimulated endothelial cells","volume":"81","author":"De Boer","year":"1994","journal-title":"Immunology"},{"key":"10.1016\/j.jid.2022.06.016_bib10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3324\/haematol.2013.098145","article-title":"Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas","volume":"99","author":"de Masson","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.jid.2022.06.016_bib11","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/sj.leu.2400745","article-title":"Diminished TCR signaling in cutaneous T cell lymphoma is associated with decreased activities of Zap70, Syk and membrane-associated CSK","volume":"11","author":"Fargnoli","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.jid.2022.06.016_bib13","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1182\/blood.V99.3.800","article-title":"Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients","volume":"99","author":"Fink-Puches","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.06.016_bib14","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/40166","article-title":"Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells","volume":"389","author":"Fuhlbrigge","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jid.2022.06.016_bib15","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.3390\/ijms21176239","article-title":"Knockdown of \u03b12,3-sialyltransferases impairs pancreatic cancer cell migration, invasion and E-selectin-dependent adhesion","volume":"21","author":"Guerrero","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2022.06.016_bib16","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1182\/blood.2020009346","article-title":"Multimodal single-cell analysis of cutaneous T cell lymphoma reveals distinct sub-clonal tissue-dependent signatures","volume":"138","author":"Herrera","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.06.016_bib17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1600-0560.1998.tb01766.x","article-title":"Comparative analysis of histological and immunohistological features in mycosis fungoides and Sezary syndrome","volume":"25","author":"Kamarashev","year":"1998","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.jid.2022.06.016_bib18","doi-asserted-by":"crossref","first-page":"7275","DOI":"10.1158\/1078-0432.CCR-19-2030","article-title":"FDA approval summary: Mogamulizumab-kpkc for mycosis fungoides and S\u00e9zary syndrome","volume":"25","author":"Kasamon","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2022.06.016_bib19","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S1470-2045(18)30379-6","article-title":"Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial","volume":"19","author":"Kim","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jid.2022.06.016_bib20","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1158\/0008-5472.CAN-08-4631","article-title":"Lack of T-cell receptor\u2013induced signaling is crucial for CD95 ligand up-regulation and protects cutaneous T-cell lymphoma cells from activation-induced cell death","volume":"69","author":"Klemke","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2022.06.016_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jim.2012.07.003","article-title":"HECA-452 is a non-function blocking antibody for isolated sialyl Lewis x adhesion to endothelial expressed E-selectin under flow conditions","volume":"384","author":"Kummitha","year":"2012","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jid.2022.06.016_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.12.002","article-title":"Glycans in the immune system and the Altered Glycan Theory of Autoimmunity: a critical review","volume":"57","author":"Maverakis","year":"2015","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jid.2022.06.016_bib23","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1182\/blood-2014-07-588590","article-title":"ST3Gal-4 is the primary sialyltransferase regulating the synthesis of E-, P-, and L-selectin ligands on human myeloid leukocytes","volume":"125","author":"Mondal","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.06.016_bib24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3324\/haematol.2018.212266","article-title":"Sialyltransferase inhibition leads to inhibition of tumor cell interactions with E-selectin, VCAM1, and MADCAM1, and improves survival in a human multiple myeloma mouse model","volume":"105","author":"Natoni","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jid.2022.06.016_bib25","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.06.016_bib26","first-page":"1053","article-title":"A\u00a0unique phenotype of skin-associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites","volume":"136","author":"Picker","year":"1990","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2022.06.016_bib27","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/s41375-020-01068-2","article-title":"Xenograft and cell culture models of S\u00e9zary syndrome reveal cell of origin diversity and subclonal heterogeneity","volume":"35","author":"Poglio","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.jid.2022.06.016_bib28","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1080\/13543784.2019.1654995","article-title":"Investigative drugs for the treatment of cutaneous T-cell lymphomas (CTCL): an update","volume":"28","author":"Ramelyte","year":"2019","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jid.2022.06.016_bib29","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1182\/blood-2017-03-772996","article-title":"Circulating and skin-derived S\u00e9zary cells: clonal but with phenotypic plasticity","volume":"130","author":"Roelens","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.06.016_bib30","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/bjh.15547","article-title":"Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma","volume":"183","author":"Seto","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jid.2022.06.016_bib31","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1080\/14712598.2021.1858791","article-title":"Near infrared photoimmunotherapy targeting the cutaneous lymphocyte antigen for mycosis fungoides","volume":"21","author":"Silic-Benussi","year":"2021","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.jid.2022.06.016_bib32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1365-2133.2004.06325.x","article-title":"Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7","volume":"152","author":"Sokolowska-Wojdylo","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2022.06.016_bib33","doi-asserted-by":"crossref","first-page":"6868","DOI":"10.3390\/ijms22136868","article-title":"Mesenchymal stromal cells regulate sialylations of N-glycans, affecting cell migration and survival","volume":"22","author":"Templeton","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2022.06.016_bib34","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.it.2017.02.002","article-title":"PSGL-1: a new player in the immune checkpoint landscape","volume":"38","author":"Tinoco","year":"2017","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jid.2022.06.016_bib35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ajh.24233","article-title":"Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management","volume":"91","author":"Wilcox","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jid.2022.06.016_bib36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF02631086","article-title":"Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides","volume":"28A","author":"Kaltoft","year":"1992","journal-title":"Vitro Cell Dev Biol"},{"key":"10.1016\/j.jid.2022.06.016_bib37","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X22016682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X22016682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:50:28Z","timestamp":1762206628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X22016682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0022202X22016682"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2022.06.016","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742240116.793594330","asserted-by":"object"}]},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous Lymphocyte Antigen Is a Potential\u00a0Therapeutic Target in Cutaneous T-Cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2022.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}